TERMIUM Plus®

From: Translation Bureau

On social media

Consult the Government of Canada’s terminology data bank.

GLUCAGON-LIKE PEPTIDE-1 [3 records]

Filter results by subject field Alphabetical list of terms

Filter results by subject field

Alphabetical list of terms

Record 1 2024-11-15

English

Subject field(s)
  • Hormones
  • Biochemistry
CONT

The incretins are gastrointestinal polypeptide hormones that act to modulate insulin secretion from pancreatic beta cells. These hormones include glucagon-like peptide-1(GLP-1) and gastric inhibitory peptide(GIP), and they are secreted from the upper gastrointestinal tract in response to feeding.

French

Domaine(s)
  • Hormones
  • Biochimie
CONT

Les incrétines sont sécrétées par le tube digestif lors de la prise d'un repas. Elles stimulent la sécrétion d'insuline par les cellules bêta du pancréas lorsque la glycémie est trop élevée (glycémie postprandiale), mais sans risque d'hypoglycémie.

Spanish

Save record 1

Record 2 2024-10-30

English

Subject field(s)
  • Hormones
  • Bowels
CONT

GLP-1(glucagon-like peptide-1) is a gut hormone which is released into the blood stream after feeding. Its main action is to stimulate insulin secretion through potentiating the insulinotropic action of glucose. The peptide is encoded in the glucagon gene and expressed mainly in the gut L cells.

French

Domaine(s)
  • Hormones
  • Intestins

Spanish

Save record 2

Record 3 2024-07-18

English

Subject field(s)
  • Chemical Elements and Compounds
  • Medication
  • Endocrine System and Metabolism
CONT

Semaglutide belongs to a class of medications known as glucagon-like peptide-1(GLP-1) receptor agonists. It mimics the GLP-1 hormone that is released in the gastrointestinal tract in response to eating. One role of GLP-1 is to prompt the body to produce more insulin, which reduces blood glucose(sugar). GLP-1 in higher amounts also interacts with the parts of the brain that reduce appetite and signal a feeling of fullness.

French

Domaine(s)
  • Éléments et composés chimiques
  • Médicaments
  • Systèmes endocrinien et métabolique
CONT

Le sémaglutide est un analogue du GLP-1 [qui] agit comme agoniste des récepteurs du GLP-1 [...] Le sémaglutide réduit la glycémie de façon glucose-dépendante en stimulant la sécrétion d'insuline et en réduisant la sécrétion de glucagon lorsque la glycémie est élevée. Le mécanisme de réduction de la glycémie entraîne également un léger retard de la vidange gastrique en début de phase postprandiale. Lors d'une hypoglycémie, le sémaglutide diminue la sécrétion d'insuline sans altérer la sécrétion du glucagon.

Spanish

Save record 3

Copyright notice for the TERMIUM Plus® data bank

© Public Services and Procurement Canada, 2026
TERMIUM Plus®, the Government of Canada's terminology and linguistic data bank
A product of the Translation Bureau

Display options

Change the order of display of the official languages of Canada
Option to display the non-official languages (Spanish or Portuguese)
Display definitions, contexts, etc., on records

Features

GCtranslate (available on the Government of Canada network only)

Use this artificial intelligence prototype to translate Government of Canada content up to and including Protected B. Available to employees of selected departments and agencies only.

Writing tools

The Language Portal’s writing tools have a new look! Easy to consult, they give you access to a wealth of information that will help you write better in English and French.

Glossaries and vocabularies

Access Translation Bureau glossaries and vocabularies.

Date Modified: